InBody Co.,Ltd

KOSDAQ 041830.KQ

InBody Co.,Ltd Total Assets for the year ending December 31, 2023: USD 210.78 M

InBody Co.,Ltd Total Assets is USD 210.78 M for the year ending December 31, 2023, a 9.95% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

InBody Co.,Ltd Total Assets for the year ending December 31, 2022 was USD 191.71 M, a 12.41% change year over year.
InBody Co.,Ltd Total Assets for the year ending December 31, 2021 was USD 170.55 M, a 11.82% change year over year.
InBody Co.,Ltd Total Assets for the year ending December 31, 2020 was USD 152.53 M, a 14.23% change year over year.
InBody Co.,Ltd Total Assets for the year ending December 31, 2019 was USD 133.53 M, a 13.42% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

KOSDAQ: 041830.KQ

InBody Co.,Ltd

CEO	Dr. Ki-Chul Cha
IPO Date	Dec. 15, 2000
Location	South Korea
Headquarters	InBody Building
Employees	266
Sector	Health Care
Industries Medical Instruments Cosmetics Pharmaceuticals

Description

InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years